Yuval Cohen insider trades
Open-market stock purchases and sales by Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc, from SEC Form 4 filings since Dec 3, 2014.
Track record: 100% of 19 scored buys are up 5% or more since purchase, averaging +98%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 13, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc | Sold | $108K |
| Jan 14, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc | Bought (not open market) | — |
| Jan 14, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc | Bought (not open market) | — |
| Oct 27, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc | Sold | $154K |
| Oct 27, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc | Bought (not open market) | — |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc | Sold | $317K |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc | Bought (not open market) | — |
Companies traded
- CRBP Corbus Pharmaceuticals Holdings, Inc: 27 buys, 12 sales, last Feb 13, 2026